INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 51 filers reported holding INOZYME PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11,726,719 | -36.7% | 2,629,309 | +8.7% | 0.00% | – |
| Q1 2024 | $18,529,693 | +82.4% | 2,419,020 | +1.4% | 0.00% | – |
| Q4 2023 | $10,160,194 | +6.3% | 2,385,022 | +4.8% | 0.00% | – |
| Q3 2023 | $9,559,557 | +22.9% | 2,276,085 | +63.1% | 0.00% | – |
| Q2 2023 | $7,775,218 | +2.2% | 1,395,910 | +5.1% | 0.00% | – |
| Q1 2023 | $7,611,102 | +439.5% | 1,328,290 | -1.1% | 0.00% | – |
| Q4 2022 | $1,410,803 | -60.8% | 1,343,622 | +0.0% | 0.00% | – |
| Q3 2022 | $3,599,000 | -44.3% | 1,343,063 | -0.8% | 0.00% | – |
| Q2 2022 | $6,460,000 | +222.5% | 1,354,216 | +176.6% | 0.00% | – |
| Q1 2022 | $2,003,000 | -39.9% | 489,613 | +0.2% | 0.00% | – |
| Q4 2021 | $3,333,000 | -53.0% | 488,719 | -20.0% | 0.00% | – |
| Q3 2021 | $7,084,000 | +24.0% | 611,185 | +82.3% | 0.00% | – |
| Q2 2021 | $5,713,000 | -15.4% | 335,286 | -1.7% | 0.00% | – |
| Q1 2021 | $6,751,000 | +5.8% | 340,964 | +10.3% | 0.00% | – |
| Q4 2020 | $6,380,000 | -18.3% | 309,114 | +4.1% | 0.00% | – |
| Q3 2020 | $7,809,000 | – | 297,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,591,154 | $27,113,000 | 10.69% |
| Burrage Capital Management LLC | 242,517 | $4,132,000 | 4.14% |
| CHI Advisors LLC | 927,264 | $15,801,000 | 3.68% |
| Sofinnova Investments, Inc. | 2,028,308 | $34,562,000 | 1.99% |
| Novo Holdings A/S | 1,867,706 | $31,826,000 | 1.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,178,985 | $37,130,000 | 0.66% |
| RA Capital Management | 2,003,653 | $34,142,000 | 0.55% |
| NEA Management Company, LLC | 2,444,379 | $41,652,000 | 0.54% |
| Rock Springs Capital Management LP | 840,272 | $14,318,000 | 0.28% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 365,172 | $6,223,000 | 0.09% |